Saved Papers

Save papers so you can find them more easily!

Join Now

Get instant access to over 100,000 papers.

Join Now!

Biopure Corporation

Biopure Corporation: A Quantitative way for deciding the pricing and the distribution strategy for Oxyglobin

Note: such quantitative analysis is not required for your mid term exam. However, this note will be of interest to any student who is interested in knowing how to employ a rigorous way of computing the price and the subsequent distribution strategy.

Step 1: Calculating the total potential demand for Oxyglobin:
Critical cases: We can calculate the total potential demand for dogs for the critical cases in terms of units of blood as follows:
It's given that the total no. of vet practices are 15,000. Out of these 5% (or 750) are emergency care practices and rest 14,250 are primary care practices. It is also given that a primary care practice on an average uses 17 units of donated blood and the emergency care practice uses 150 units per year. Therefore, the total demand for emergency care practices for the critical cases would be 150*750 units and that for primary care......


View the rest of this paper...

Approximate Word Count: 1019
Approximate Pages: 5 (250 words per double-spaced page)

Why should you join Frat Files?

  • - It's safe, secure, and private.
  • - Instant access to over 100,000 papers. New papers are added hourly.
  • - Fast and reliable customer support.

Credit Card

PayPal

Bank Account

Similar Essays

  1. Biopure Corporation

    Biopure Corporation Biopure Corporation: A Quantitative way for deciding the pricing and the distribution strategy for Oxyglobin Note: such quantitative analysis is not required

  2. Biopure

    Biopure Biopure Corporation Based on the review, we recommend the Biopure Corporation to launch their animal blood substitute, Oxyglobin, immediately in the market, so that it

  3. Biopure

    Biopure BIOPURE CORPORATION – BLOOD SUSTITUTE DECISION By: Rob Campbell, John Nicolaus, Satya Rao and Jim Zinski Introduction: We have reviewed the available information

  4. Biopure Case

    BioPure case BioPure Corporation, which was founded in 1984 by entrepreneurs Carl Rausch and David Judelson, is a privately owned biopharmaceutical firm specializing in the ultra

  5. Biopure

    Biopure Case Analysis: Biopure Corporation. Background Analysis: General Market Assessment: Biopure Corporation makes Blood substitutes for animals and human beings. Blood